Characteristics and prognosis of visual field of G11778A mutation Leber hereditary optic neuropathy_Chinese Journal of Ocular Fundus Diseases

Authors：

Xia Yanting ¹ ,  Liao Liang ¹ , Zhang Taotao ² , Zhou Jian ¹ , Wei Qiping ¹

1. Department of Ophthalmology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China;
2. Beijing University of Chinese Medicine, Beijing 100029, China;

Corresponding?author：

Liao Liang, Email: 58273677@qq.com

Keywords：

Visual fields; Optic atrophy, hereditary, Leber; Genes; G11778A mutation

DOI：

10.3760/cma.j.cn511434-20200427-00180

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To analyze the characteristics and prognosis of visual field of Leber hereditary optic neuropathy (LHON) with G11778A mutation.Methods A retrospective clinical study. Twenty-two (44 eyes) of LHON patients diagnosed with G11778A site mutation by mt-DNA examination from May 2008 to February 2018 in Ophthalmology Department of Dongfang Hospital of Beijing University of Chinese Medicine, were enrolled in this study. All patients underwent best corrected visual acuity (BCVA), visual field and optical coherence tomography (OCT). The BCVA examination was performed using the international standard visual acuity chart, which was converted into logarithm of the minimum angle of resolution (logMAR) BCVA for record. The thickness of the retinal nerve fiber layer (RNFL) in the 200μm×200μm annular region 1.73 mm outside the optic disc was measured by OCT. At least 7 visual field examinations were performed within one month before and after 2, 4, 8, 12, 18, 24 and 30 months of the course of disease by using Octopus 101 perimetry. Among 44 eyes, 27 eyes were detected with G2 procedure (G2 group) and 17 eyes were detected with LVC procedure (LVC group). The mean field defect (MD) and mean optical sensitivity (MS) were used as the main outcome indexes. According to the onset age, the patients were further divided into the ≤14 years old group and＞14 years old group. There was a significant difference in initial logMAR BCVA between the G2 group and LVC group (t=4.994, P=0.000), but there was no significant difference in gender (χ²=1.896, P=0.169) and age (t=0.337, P=0.708) between the two groups. Independent sample t test was used for comparison between groups, paired t test was used for comparison within groups, and one-way analysis of variance was used for comparison between groups. The statistical data were compared by χ² test.Results In the G2 group, the MD value of the subgroup of children (≤14 years old) decreased gradually during the follow-up period, and the MD value since 18 months after onset was significantly lower than the value of 2 months after onset (t=3.813, 4.590, 5.033; P=0.002, 0.001, 0.000). No obvious visual field index changes were seen in other subgroups (P＞0.05). The central scotoma was the most common type of visual field defect in the early stage, and the diffuse defect was the most common type of visual field defect in the late stage. There was a significant difference in the types of visual field distribution between the early and late stage in G2 group (χ²=17.414, P=0.015). There was no significant difference in the type of visual field distribution between the early and late stage in LVC group (χ²=4.541, P=0.474). The MD value in the G2 group remained stable within 8 months after onset, but significantly improved after 18 months after onset (t=2.100, 3.217, 3.566; P=0.046, 0.003, 0.001). The MS in the LVC group did not significantly improve during follow-up (P＞0.05). The average visual acuity of the G2 group was significantly improved from 12 months (t=3.039, 3.678, 4.264, 5.078; P=0.008, 0.002, 0.001, 0.000). The visual acuity of the eyes in the G2 group was better than that of the LVC group during all follow-up periods (P≤0.05). The RNFL thickness of all patients continued to decrease after onset, but the RNFL thickness was significantly higher at 4, 8, 18, 24, 30 months in the G2 group than those in the LVC group (t=2.471, 2.269, 2.474, 2.509, 2.782; P=0.018, 0.028, 0.017, 0.016, 0.008).Conclusions The main types of visual field defect of LHON with G11778A mutation are the central scotoma in the early stage, while the diffuse defect and central scotoma are both very common in the later stage. The visual field of LHON patients examined by G2 procedure is significantly improved during the follow-up, as well as the visual acuity improved significantly, and the visual field improvement in younger cases (≤14 years old) is better than that of older cases (＞14 years old), but the visual field of the LVC procedure cases did not improve during follow-up.

Citation： Xia Yanting, Liao Liang, Zhang Taotao, Zhou Jian, Wei Qiping. Characteristics and prognosis of visual field of G11778A mutation Leber hereditary optic neuropathy. Chinese Journal of Ocular Fundus Diseases, 2021, 37(3): 180-188. doi: 10.3760/cma.j.cn511434-20200427-00180 Copy

1.	張麗珊, 黃鷹, 李方園, 等. 中國人Leber遺傳性視神經病家系線粒體DNA突變的研究[J]. 中華醫學雜志, 1994, 74(6): 349-351.Zhang LS, Huang Y, Li FY, et al. Mitochondrial DNA mutation in Leber's hereditaryoptic neuropathy in China[J]. Natl Med J China, 1994, 74(6): 349-351.
2.	郭莉, 賈小云, 肖學珊, 等. 原因不明的視神經炎線粒體DNA突變檢測[J]. 中華眼底病雜志, 2000, 16(2): 78-79.Guo L, Jia XY, Xiao XS, et al. Screening for mt-DNA mutations in optic neuritis of unknown reason[J]. Chin J Ocul Fundus Dis, 2000, 16(2): 78-79.
3.	韋企平, 孫艷紅, 宮曉紅, 等. 中國人Leber遺傳性視神經病變線粒體DNA突變的主要類型和臨床特征[J]. 中華眼底病雜志, 2004, 20(2): 78-80.Wei QP, Sun YH, Gong XH, et al. The main types and clinical features of mitochondrial DNA mutations in Chinese Leber hereditary optic neuropathy[J]. Chin J Ocul Fundus Dis, 2004, 20(2): 78-80.
4.	祝肇榮, 盧俊. LVC程序視野檢查在青光眼合并白內障患者的應用[J]. 上海第二醫科大學學報, 2003, 23(5): 455-457. DOI: 10.3969/j.issn.1674-8115.2003.05.022.Zhu ZR, Lu J. Application of LVC procedure visual field examination in patients with glaucoma and cataract[J]. Journal of Shanghai Second Medical University, 2003, 23(5): 455-457. DOI: 10.3969/j.issn.1674-8115.2003.05.022.
5.	Nowomiejska K, Kiszka A, Koman-Wierdak E, et al. Analysis of visual field defects obtained with semiautomated kinetic perimetry in patients with Leber hereditary optic neuropathy[J/OL]. J Ophthalmol, 2018, 2018: 5985702[2018-03-21]. https://doi.org/10.1155/2018/5985702. DOI: 10.1155/2018/5985702.
6.	Newman NJ, Biousse V, Newman SA, et al. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial[J]. Am J Ophthalmol, 2005, 141(6): 1061-1067. DOI: 10.1016/j.ajo.2005.12.045.
7.	韋企平, 路明, 張麗霞, 等. Leber遺傳性視神經病變24例臨床分析[J]. 北京中醫藥大學學報, 2001, 24(2): 62-64. DOI: 10.3321/j.issn: 1006-2157.2001.02.024.Wei QP, Lu M, Zhang LX, et al. Clinical analysis of 24 cases of Leber hereditary optic neuropathy[J]. Journal of Beijing University of Traditional Chinese Medicine, 2001, 24(2): 62-64. DOI: 10.3321/j.issn: 1006-2157.2001.02.024.
8.	程先華, 楊沫, 魏世輝, 等. Leber遺傳性視神經病變的臨床特點[J]. 眼科, 2017, 26(5): 343-346. DOI: 10.13281/j.cnki.issn.1004-4469.2017.05.012.Cheng XH, Yang M, Wei SH, et al. Clinical characteristics of Leber's hereditary optic neuropathy[J]. Ophthalmology, 2017, 26(5): 343-346. DOI: 10.13281/j.cnki.issn.1004-4469.2017.05.012.
9.	Yum HR, Chae H, Shin SY, et al. Pathogenic mitochondrial DNA mutations and associated clinical featurs in Korean patients with Leber's hereditary optic neuropathy[J]. Invest Ophthalmol Vis Sci, 2014, 55(12): 8095-8101. DOI: 10.1167/iovs.14-15311.
10.	Ran R, Yang S, He H, et al. A retrospective analysis of characteristics of visual field damage in patients with Leber’s hereditary optic neuropathy[J/OL]. Springerplus, 2016, 5(1): 843[2016-01-23]. http://europepmc.org/article/MED/27386292. DOI: 10.1186/s40064-016-2540-7.
11.	王瑛, 樊寧, 劉旭陽, 等. G11778A位點突變的9例Leber遺傳性視神經病變患者的臨床特征[J]. 國際眼科雜志, 2016, 16(10): 1952-1955. DOI: 10.3980/j.issn.1672-5123.2016.10.44.Wang Y, Fan N, Liu XY, et al. Clinical characteristics of 9 Leber hereditary optic neuropathy patients with G11778A mutation[J]. Int Eye Sci, 2016, 16(10): 1952-1955. DOI: 10.3980/j.issn.1672-5123.2016.10.44.
12.	Sadun AA, Salomao SR, Berezovsky A, et al. Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study[J]. Trans Am Ophthalmol Soc, 2006, 104: 51-61.
13.	Hwang TJ, Karanjia R, Moraes-Filho MN, et al. Natural history of conversion of Leber's hereditary optic neuropathy: a prospective case series[J]. Ophthalmology, 2017, 124(6): 843-850. DOI: 10.1016/j.ophtha.2017.01.002.
14.	韋企平, 孫艷紅. Leber遺傳性視神經病變的臨床和基礎研究現狀[J]. 中國中醫眼科雜志, 2010, 20(2): 63-66.Wei QP, Sun YH. Current status of clinical and basic research on Leber's hereditary optic neuropathy[J]. Chinese Journal of Chinese Ophthalmology, 2010, 20(2): 63-66.
15.	Oostra RJ, Bolhuis PA, Wijburg FA, et al. Leber's hereditary optic neuropathy: correlations between mitochondrial genotype and visual outcome[J]. J Med Genet, 1994, 31(4): 280-286. DOI: 10.1136/jmg.31.4.280.
16.	Moon Y, Kim US, Han J, et al. Clinical and optic disc characteristics of patients showing visual recovery in Leber hereditary optic neuropathy[J]. J Neuroophthalmol, 2020, 40(1): 15-21. DOI: 10.1097/WNO.0000000000000830.
17.	Liu HL, Yuan JJ, Tian Z, et al. What are the characteristics and progression of visual field defects in patients with Leber hereditary optic neuropathy: a prospective single-centre study in China[J/OL]. BMJ open, 2019, 9(3): e025307[2019-03-15]. http://europepmc.org/article/MED/30878986. DOI: 10.1136/bmjopen-2018-025307.

1. 張麗珊, 黃鷹, 李方園, 等. 中國人Leber遺傳性視神經病家系線粒體DNA突變的研究[J]. 中華醫學雜志, 1994, 74(6): 349-351.Zhang LS, Huang Y, Li FY, et al. Mitochondrial DNA mutation in Leber's hereditaryoptic neuropathy in China[J]. Natl Med J China, 1994, 74(6): 349-351.
2. 郭莉, 賈小云, 肖學珊, 等. 原因不明的視神經炎線粒體DNA突變檢測[J]. 中華眼底病雜志, 2000, 16(2): 78-79.Guo L, Jia XY, Xiao XS, et al. Screening for mt-DNA mutations in optic neuritis of unknown reason[J]. Chin J Ocul Fundus Dis, 2000, 16(2): 78-79.
3. 韋企平, 孫艷紅, 宮曉紅, 等. 中國人Leber遺傳性視神經病變線粒體DNA突變的主要類型和臨床特征[J]. 中華眼底病雜志, 2004, 20(2): 78-80.Wei QP, Sun YH, Gong XH, et al. The main types and clinical features of mitochondrial DNA mutations in Chinese Leber hereditary optic neuropathy[J]. Chin J Ocul Fundus Dis, 2004, 20(2): 78-80.
4. 祝肇榮, 盧俊. LVC程序視野檢查在青光眼合并白內障患者的應用[J]. 上海第二醫科大學學報, 2003, 23(5): 455-457. DOI: 10.3969/j.issn.1674-8115.2003.05.022.Zhu ZR, Lu J. Application of LVC procedure visual field examination in patients with glaucoma and cataract[J]. Journal of Shanghai Second Medical University, 2003, 23(5): 455-457. DOI: 10.3969/j.issn.1674-8115.2003.05.022.
5. Nowomiejska K, Kiszka A, Koman-Wierdak E, et al. Analysis of visual field defects obtained with semiautomated kinetic perimetry in patients with Leber hereditary optic neuropathy[J/OL]. J Ophthalmol, 2018, 2018: 5985702[2018-03-21]. https://doi.org/10.1155/2018/5985702. DOI: 10.1155/2018/5985702.
6. Newman NJ, Biousse V, Newman SA, et al. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial[J]. Am J Ophthalmol, 2005, 141(6): 1061-1067. DOI: 10.1016/j.ajo.2005.12.045.
7. 韋企平, 路明, 張麗霞, 等. Leber遺傳性視神經病變24例臨床分析[J]. 北京中醫藥大學學報, 2001, 24(2): 62-64. DOI: 10.3321/j.issn: 1006-2157.2001.02.024.Wei QP, Lu M, Zhang LX, et al. Clinical analysis of 24 cases of Leber hereditary optic neuropathy[J]. Journal of Beijing University of Traditional Chinese Medicine, 2001, 24(2): 62-64. DOI: 10.3321/j.issn: 1006-2157.2001.02.024.
8. 程先華, 楊沫, 魏世輝, 等. Leber遺傳性視神經病變的臨床特點[J]. 眼科, 2017, 26(5): 343-346. DOI: 10.13281/j.cnki.issn.1004-4469.2017.05.012.Cheng XH, Yang M, Wei SH, et al. Clinical characteristics of Leber's hereditary optic neuropathy[J]. Ophthalmology, 2017, 26(5): 343-346. DOI: 10.13281/j.cnki.issn.1004-4469.2017.05.012.
9. Yum HR, Chae H, Shin SY, et al. Pathogenic mitochondrial DNA mutations and associated clinical featurs in Korean patients with Leber's hereditary optic neuropathy[J]. Invest Ophthalmol Vis Sci, 2014, 55(12): 8095-8101. DOI: 10.1167/iovs.14-15311.
10. Ran R, Yang S, He H, et al. A retrospective analysis of characteristics of visual field damage in patients with Leber’s hereditary optic neuropathy[J/OL]. Springerplus, 2016, 5(1): 843[2016-01-23]. http://europepmc.org/article/MED/27386292. DOI: 10.1186/s40064-016-2540-7.
11. 王瑛, 樊寧, 劉旭陽, 等. G11778A位點突變的9例Leber遺傳性視神經病變患者的臨床特征[J]. 國際眼科雜志, 2016, 16(10): 1952-1955. DOI: 10.3980/j.issn.1672-5123.2016.10.44.Wang Y, Fan N, Liu XY, et al. Clinical characteristics of 9 Leber hereditary optic neuropathy patients with G11778A mutation[J]. Int Eye Sci, 2016, 16(10): 1952-1955. DOI: 10.3980/j.issn.1672-5123.2016.10.44.
12. Sadun AA, Salomao SR, Berezovsky A, et al. Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study[J]. Trans Am Ophthalmol Soc, 2006, 104: 51-61.
13. Hwang TJ, Karanjia R, Moraes-Filho MN, et al. Natural history of conversion of Leber's hereditary optic neuropathy: a prospective case series[J]. Ophthalmology, 2017, 124(6): 843-850. DOI: 10.1016/j.ophtha.2017.01.002.
14. 韋企平, 孫艷紅. Leber遺傳性視神經病變的臨床和基礎研究現狀[J]. 中國中醫眼科雜志, 2010, 20(2): 63-66.Wei QP, Sun YH. Current status of clinical and basic research on Leber's hereditary optic neuropathy[J]. Chinese Journal of Chinese Ophthalmology, 2010, 20(2): 63-66.
15. Oostra RJ, Bolhuis PA, Wijburg FA, et al. Leber's hereditary optic neuropathy: correlations between mitochondrial genotype and visual outcome[J]. J Med Genet, 1994, 31(4): 280-286. DOI: 10.1136/jmg.31.4.280.
16. Moon Y, Kim US, Han J, et al. Clinical and optic disc characteristics of patients showing visual recovery in Leber hereditary optic neuropathy[J]. J Neuroophthalmol, 2020, 40(1): 15-21. DOI: 10.1097/WNO.0000000000000830.
17. Liu HL, Yuan JJ, Tian Z, et al. What are the characteristics and progression of visual field defects in patients with Leber hereditary optic neuropathy: a prospective single-centre study in China[J/OL]. BMJ open, 2019, 9(3): e025307[2019-03-15]. http://europepmc.org/article/MED/30878986. DOI: 10.1136/bmjopen-2018-025307.

Chinese Journal of Ocular Fundus Diseases

Characteristics and prognosis of visual field of G11778A mutation Leber hereditary optic neuropathy

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content